Viral immunology is a specialized field of study that investigates the host immune responses to viral infections and the mechanisms viruses employ to evade or manipulate the immune system. The complex interplay between viruses and the host immune system involves intricate cellular and molecular interactions. In viral immunology, researchers examine how the innate and adaptive immune responses recognize and combat viral invaders. Key components include the identification of viral antigens, the activation of immune cells like T cells and B cells, and the production of antiviral antibodies. Understanding viral immunology is essential for vaccine development, as vaccines leverage the immune system's ability to recognize and remember viral threats. Additionally, research in this field contributes to antiviral drug development, aiming to disrupt viral replication without compromising the host's immune function. Viral immunology also explores the concept of immunoevasion, where viruses employ strategies to subvert or evade immune surveillance. Ongoing advancements in this field contribute to our ability to design effective interventions to prevent and treat viral infections.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States